CXCL8 and plasma cell myeloma: CXCL8 serum levels in patients with multiple myeloma, a cancer originating in bone marrow plasma cells, were elevated compared to healthy controls, and multiple myeloma cells upregulated CXCL8 expression in bone stromal cells (183–186).